References
1. Koch WC. Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 2001;14:343–56.
2. Douvoyiannis M, Litman N, Goldman DL. Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis 2009;48:1713–23.
3. Barah F, Vallely PJ, Cleator GM, Kerr JR. Neurological manifestations of human parvovirus B19 infection. Rev Med Virol 2003;13:185–99.
4. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 2001;358:729–30.
5. Bonvicini F, Marinacci G, Pajno MC, Gallinella G, Musiani M, Zerbini M. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman. Clin Infect Dis 2008;47:385–7.
6. Tonnellier M, Bessereau J, Carbonnell N, Guidet B, Méritet JF, Kerr JR, et al. A possible parvovirus B19 encephalitis in an immunocompetent adult patient. J Clin Virol 2007;38:186–7.
7. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006;260:285–304.
8. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350:586–97.
9. Kerr JR, Barah F, Chiswick ML, McDonnell GV, Smith J, Chapman MD, et al. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatry 2002;73:739–46.
10. Isumi H, Nunoue T, Nishida A, Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol 1999;21:661–3.